SMTL ID : 6qex.1

Nanodisc reconstituted human ABCB1 in complex with UIC2 fab and taxol

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 3 residues within 4Å: Chain A: N.91, I.92, T.93 No protein-ligand interaction detected (PLIP) NAG.2: 1 residues within 4Å: Chain A: N.94 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.94 NAG.3: 2 residues within 4Å: Chain A: I.98, N.99 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.99

16 x CLR: CHOLESTEROL(Non-covalent)

CLR.4: 8 residues within 4Å: Chain A: T.112, A.115, Y.116, S.119, M.948, F.951 Ligands: CLR.5, CLR.10 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:T.112, A:A.115, A:Y.116, A:F.951 CLR.5: 9 residues within 4Å: Chain A: I.864, M.948, F.951, S.952, G.955, R.958, F.959 Ligands: CLR.4, CLR.11 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.864, A:F.959, A:F.959 CLR.6: 4 residues within 4Å: Chain A: N.839, I.840, L.843, I.848 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:N.839, A:I.840, A:L.843, A:L.843, A:I.848 CLR.7: 5 residues within 4Å: Chain A: L.843, L.862, V.865, P.866, A.869 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.843, A:L.862, A:V.865, A:P.866 CLR.8: 9 residues within 4Å: Chain A: L.305, A.308, A.311, L.312, W.315, N.753, S.756, L.757, L.760 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.305, A:A.308, A:A.311, A:L.312, A:L.312, A:W.315, A:L.757, A:L.760 Hydrogen bonds: A:N.753 CLR.9: 5 residues within 4Å: Chain A: L.67, E.74, Y.117, G.120, I.121 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.67, A:Y.117, A:Y.117 Hydrogen bonds: A:E.74 CLR.10: 3 residues within 4Å: Chain A: S.119, G.120 Ligands: CLR.4 No protein-ligand interaction detected (PLIP) CLR.11: 4 residues within 4Å: Chain A: A.863, F.959 Ligands: CLR.5, CLR.12 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:A.863, A:F.959 CLR.12: 6 residues within 4Å: Chain A: Q.856, L.859, L.862, A.863, F.959 Ligands: CLR.11 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.859, A:L.862, A:F.959 CLR.13: 6 residues within 4Å: Chain A: A.220, I.221, L.312, W.315, Y.316 Ligands: CLR.17 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.221, A:L.312, A:L.312, A:W.315 CLR.14: 6 residues within 4Å: Chain A: T.845, I.848, I.849, I.852, Y.853 Ligands: CLR.15 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.848, A:I.849, A:I.852 Hydrogen bonds: A:Y.853 CLR.15: 4 residues within 4Å: Chain A: G.723, A.727, F.755 Ligands: CLR.14 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:A.727 CLR.16: 2 residues within 4Å: Chain A: F.851, W.855 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.851, A:W.855, A:W.855 CLR.17: 3 residues within 4Å: Chain A: L.216, A.220 Ligands: CLR.13 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.216, A:A.220 CLR.18: 5 residues within 4Å: Chain A: Y.50, Y.130, F.135, H.936 Ligands: CLR.19 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.130, A:F.135, A:F.135 CLR.19: 5 residues within 4Å: Chain A: L.46, L.49, V.53, L.56 Ligands: CLR.18 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.46, A:L.49, A:V.53, A:L.56

1 x TA1: TAXOL(Non-covalent)

TA1.20: 16 residues within 4Å: Chain A: M.69, W.232, Y.307, Y.310, F.336, L.339, I.340, F.343, S.344, Q.347, Q.725, Q.946, Y.953, F.983, M.986, Q.990 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:Y.307, A:F.336, A:L.339, A:I.340, A:F.343, A:F.343, A:F.343, A:F.983, A:F.983, A:M.986, A:Q.990 Hydrogen bonds: A:Y.307, A:Y.310, A:Q.347, A:Q.725, A:Q.725, A:Q.990

2 x 3PE: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)

3PE.21: 10 residues within 4Å: Chain A: M.197, F.200, L.219, P.223, G.226, L.227, A.230, V.345, S.349, I.352 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.200, A:L.219, A:V.345, A:V.345 3PE.22: 7 residues within 4Å: Chain A: F.37, F.40, M.51, T.55, I.59, F.193, F.355 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:T.55, A:I.59, A:F.193, A:F.193, A:F.355 Salt bridges: A:K.48

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Alam, A. et al., Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science (2019)

Release Date

2019-02-27

Peptides

Multidrug resistance protein 1: A
UIC2 Fab lightchain: B
UIC2 Fab heavy chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Multidrug resistance protein 1

UIC2 Fab lightchain

UIC2 Fab heavy chain

Related Entries With Identical Sequence